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Abstract
Introduction
Non-tuberculous mycobacteria (NTM) can cause disease which can be clinically and radio-
logically undistinguishable from tuberculosis (TB), posing a diagnostic and therapeutic chal-
lenge in high TB settings. We aim to describe the prevalence of NTM isolation and its clinical
characteristics in children from rural Mozambique.
Methods
This study was part of a community TB incidence study in children <3 years of age. Gas-
tric aspirate and induced sputum sampling were performed in all presumptive TB cases
and processed for smear testing using fluorochrome staining and LED Microscopy, liquid
and solid culture, and molecular identification by GenoType® Mycobacterium CM/AS
assays.
Results
NTM were isolated in 26.3% (204/775) of children. The most prevalent NTM species was M.
intracellulare (N = 128), followed by M. scrofulaceum (N = 35) and M. fortuitum (N = 9). Chil-
dren with NTM were significantly less symptomatic and less likely to present with an abnor-
mal chest radiograph than those with M. tuberculosis. NTM were present in 21.6% of follow-
up samples and 25 children had the same species isolated from2 separate samples. All
were considered clinically insignificant and none received specific treatment. Children with
NTM isolates had equal all cause mortality and likelihood of TB treatment as those with neg-
ative culture although they were less likely to have TB ruled out.
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Conclusions
NTM isolation is frequent in presumptive TB cases but was not clinically significant in this
patient cohort. However, it can contribute to TB misdiagnosis. Further studies are needed to
understand the epidemiology and the clinical significance of NTM in children.
Introduction
Non-tuberculous mycobacteria (NTM) are a large family of acid-fast bacteria, widespread in
the environment and common in soil and water [1]. In children, the most frequent NTM dis-
ease is cervicofacial lymphadenitis, followed by skin and soft tissue infections. It can occasion-
ally produce lung disease and disseminated infection, although the latter are extremely rare in
the absence of genetic disorders (cystic fibrosis and mendelian susceptibility to mycobacterial
disease) or acquired immunodeficiency [2–4].
Childhood TB is a frequent cause of lung disease in high TB endemic countries[5]. How-
ever, underdetection is common [6], partially due to the inherent difficulties in obtaining
respiratory samples in children, coupled to the paucibacillary nature of TB in this age group
[5]. An additional layer of complexity is posed by the fact that NTM lung disease and tubercu-
losis (TB) have overlapping clinical and radiological manifestations. This poses a diagnostic
and therapeutic challenge in high TB settings where sophisticated laboratory services are
unavailable[7]. Moreover, it has been suggested that NTM may have an effect on the response
to BCG vaccination and a better understanding of this association is needed in the context of
novel tuberculosis vaccine assessment[8].
The epidemiology of NTM varies by world region, however there are few studies report-
ing NTM isolation in the pediatric population, especially in low resource TB endemic set-
tings[9–11]. Little data is available on the epidemiology and clinical burden of this neglected
cousin of TB. The objective of this study is to determine the prevalence and describe the clin-
ical characteristics associated with NTM isolation in young children in a rural area of South-
ern Mozambique.
Materials and Methods
Study setting
This study was conducted at the Manhic¸a Health Research Center (CISM), located in Southern
Mozambique, a semi-rural area with a high burden of HIV and TB[12]. The region is a farm-
ing area where 38% of the households have formal housing and 55% are supplied with piped
water [13]. The Bacille Calmette-Guerin (BCG) vaccination coverage is above 95% [14].
Study design
This study was part of a larger prospective descriptive study assessing the minimum com-
munity incidence of TB among young children (<3 years of age) over a 1-year period (Octo-
ber 2011–2012)[15]. TB cases were classified according to the NIH classification [16]. This
study showed that the incidence rate of TB among children aged less than 3 years was
470/100,000person-years, with a low estimated case detection rate of 40.8% (95% CI 36.6–
45.1%)[6,15].
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Clinical procedures
Children with symptoms suspicious of TB and those in close contact with a sputum smear-
positive TB case were recruited through active and passive case detection system and evaluated
through physical examination, HIV rapid antibody test (Determine1, Abbott Laboratories),
tuberculin skin test (TST) and a chest radiograph (CXR). For symptomatic cases, upon admis-
sion to the study, one induced sputum with nasopharyngeal suction (IS) and one gastric
aspirate (GA) same-day ambulatory samples were collected following standard operating pro-
cedures from each participant and evaluated by smear microscopy and culture. All participants
included had at least one follow up visit arranged within six months of recruitment regardless
of initial disease classification in order to assess symptom resolution with or without TB treat-
ment. Those who remained symptomatic were re-assessed, by repeated CXR and collection of
new samples. Full details on the study procedures are described elsewhere[15,17]. Clinical
management of newly diagnosed TB cases was performed by the National Tuberculosis Pro-
gram (NTP) according to established national guidelines.
Laboratory procedures
Sterile single use consumables were used for each clinical procedure and no prior oral cavity
decontamination took place. GA was performed placing appropriate-sized nasogastric tube in
the stomach of a child with a minimum of 4h fasting. If less than 3ml were retrieved, the stom-
ach was washed with 10 ml of normal saline pushed via NG tube. The sample was neutralized
with 2ml bicarbonate on the spot. In children >3 months of age, an additional sample was
obtained through sputum induction, which implied administration of 100μg of salbutamol by
holding chamber followed by nebulizing 5-7ml of 3% hypertonic saline. A suction catheter
was inserted through the nostril into the oropharynx and secretions were aspirated mechani-
cally Samples were transported within 4 hours of collection and processed in the TB laboratory
at CISM. The laboratory is subject to an External Quality Assurance program provided by the
National Health Laboratory Service in South Africa and is certified by the International Orga-
nization for Standardization (ISO 90001:2008 for Quality Management).
Briefly, samples were subject to digestion, decontamination and concentration with NALC/
NaOH for 15 minutes, followed by centrifugation (3000g/15min), and resuspension in 2ml of
phosphate buffered saline (PBS). Sediments were inoculated into liquid (MGIT) and solid cul-
ture media (Lowenstein Jensen; Beckton Dickison (BD) and incubated for 45 and 60 days
respectively. Smears were stained with auramine O.
Specifically, the gastric lavage specimens were processed prior to the digestion-decontami-
nation through the addition of 50mg of NALC, centrifugation at 3000 g for 15 minutes and
resuspension of the sediment in 2ml of sterile PBS.
Positive cultures were confirmed using ZN staining and immunochromatographic assay,
BD MGIT TBc Identification Test (TBc ID, Becton Dickinson, Sparks, MD) as well as Xpert
MTB/RIF (Cepheid, Sunnyvale, CA) and identified using HAIN GenoType1 Mycobacterium
CM/AS line probe assays.
Ethical approval
The study protocol was approved by the Mozambican National Bioethics Committee and
the Hospital Clinic of Barcelona Ethics Review Committee. Written informed consent was
obtained from the caretakers of all study participants.
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Data analysis and statistical considerations
Clinical data was double entered in an electronic data capture system (OpenClinica™ www.
openclinica.org) and checked for discrepancies. Statistical software for analysis was Stata 13.0
(StataCorp. 2013. Stata: Release 13. Statistical Software. College Station, TX: StataCorp LP).
The prevalence of NTM was calculated as the proportion of NTM positive cultures at initial
admission visit over those who underwent bacteriological investigation. Two children had TB
isolated at a follow-up visit (N = 2) and were excluded from the follow-up analysis.
Results
Culture results
A total of 789 presumptive TB cases were admitted for investigation in the study. Of them, 775
children had at least one mycobacterial culture result available at the initial visit: 11 had a posi-
tive culture for MTB (1.4%) and 204 had an NTM isolate (26.2%) (Table 1). The prevalence
of NTM isolate findings was 16.0% (118/738) for gastric aspirate and 15.3% (111/726) for
induced sputum. The diagnostic yield of liquid culture alone was 15.7% (109/695) for GA and
14.8% (103/698) for IS compared to 3.9% (25/641) for GA and 3.8% (25/662) for IS in solid
media alone. The overall rate of sample contamination was larger among GA vs. IS (3.8% vs.
1.8%) and solid vs. liquid culture (13.5% vs. 7.5). Among all presumptive TB cases, seven had
a positive smear (3 had an NTM isolated, one did not have culture results available and the
remaining three had negative cultures). Gastric aspiration was able to identify a larger number
of M. tuberculosis (MTB) isolates than IS (7 vs. 4). All MTB cases were positive on liquid cul-
ture and only 4 of them were also positive on solid media.
Mycobacterial culture yielded 187 identifiable NTM isolates comprising 8 different species
and 35 unidentifiable NTM. The most prevalent NTM was M. intracellulare (N = 128),
Table 1. Mycobacterial culture results per sample available at admission.
Gastric Aspirate (N, %) Induced Sputum (N, %)
Performed 773 750
Smear positive 3 0,39% 6 0,80%
Culture results available 767 99,22% 739 98,53%
Liquid culture
Contaminated 72 9,39% 41 5,55%
Negative 579 75,49% 591 79,97%
NTM 109 15,71% 103 14,76%
MTB 7 1,01% 4 0,57%
Solid culture
Contaminated 126 16,43% 77 10,42%
Negative 615 80,18% 634 85,79%
NTM 25 3,90% 25 3,78%
MTB 1 0,16% 3 0,45%
Liquid plus solid culture
Contaminated 29 3,78% 13 1,76%
Negative 613 79,92% 611 82,68%
NTM 118 15,99% 111 15,29%
MTB 7 0,95% 4 0,55%
Abbreviations: NTM: Nontuberculous mycobacteria; MTB: M. tuberculosis. Footnote: % of NTM and MTB among uncontaminated samples
doi:10.1371/journal.pone.0169757.t001
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followed by M. scrofulaceum (N = 35) and M. fortuitum (N = 9) (Table 2). NTM were isolated
both in GA and IS in 25 children, 9 of them had the same NTM species (all of them were M.
intracellulare). Two or more NTM species were isolated in 18 children; two cases had both iso-
lates identified in the same sample.
Clinical characteristics associated with NTM isolation
Among those with NTM isolates, 42.2% were female and 52.5% were between 12 and 23
months of age (Table 3). The prevalence of NTM isolates slightly increased with age (from
22% in the first year to 27% in the third year of life) and a BCG scar was present in 84.3% of
the cases. The most frequent clinical feature at enrolment was malnutrition (89.7%) followed
by prolonged cough (18.1%). At physical examination, two children had lymphadenopathy
(one was cervical and one was a fistulized inguinal node) and 4 had an abnormal lung exami-
nation. Fifteen percent had a positive TST and 11.8% were HIV positive. At admission, 35 chil-
dren had abnormal CXR (17.6%).
Compared to children with NTM isolates, those with MTB were sicker: they had more
number of outpatient department visits in the previous year (OR 5.97, 95% CI 1.64–21.69,
p = 0.01), presented more symptoms (OR 4.92, 95% CI 1.39–17.37 p = 0.006), and were more
likely to present with an abnormal CXR (OR 16.4, 95% CI 3.00–89.60 p<0.001). There were
no differences in TST or HIV positivity.
There was no significant difference between the prevalence of the NTM at admission in
HIV-infected and uninfected TB presumptive cases (25 vs. 30%, respectively).
Follow-up data and outcomes
Twenty-five children were identified as having the same NTM species isolated from at least
two separate IS or GA samples (all except for two were M. intracellulare). Three fulfilled the
microbiological criteria for diagnosing NTM lung disease[18] and had pulmonary symptoms
plus abnormal CXR. However, these isolates were considered clinically insignificant. None of
the children were treated for NTM disease, one received TB treatment and there were no
deaths registered two years post admission.
We did not find any difference regarding mortality or likelihood of TB treatment initiation
in those cases who had an NTM isolated compared to those with a negative culture, supporting
the clinical insignificance of NTM isolates (Table 4). However, children with NTM were more
Table 2. Frequency of different specimens according to sample type.
SAMPLES PATIENTS (Gastric aspirate plus
induced sputum)
NTM species Gastric aspirate
(N = 118)
Induced sputum
(N = 111)
Single isolate Coinfection
N, % N % (N) (N, %)
M. intracellulare 67 56,8% 70 63,1% 114 14 10,9%
M. scrofulaceum 17 14,4% 18 16,2% 27 8 22,9%
Mycobacterium Sp. 20 16,9% 12 10,8% 28 4 12,5%
M. fortuitum 6 5,1% 3 2,7% 8 1 11,1%
M. malmoense 2 1,7% 3 2,7% 2 3 60,0%
M. interjectum 5 4,2% 0 0,0% 2 3 60,0%
M. gordonae 1 0,8% 1 0,9% 2 0 0,0%
M. chelonae 0 0,0% 3 2,7% 1 2 66,7%
M. abscessus 0 0,0% 1 0,9% 1 0 0,0%
doi:10.1371/journal.pone.0169757.t002
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Table 3. Baseline characteristics of presumptive TB cases with at least one sample at admission according to mycobacterial culture results.
NTM (N, %) MTB (N, %) Univariate
204 11 OR (95% CI) p
Sex
male 118 57,84% 5 45,45%
female 86 42,16% 6 54,55% 0.53 (0.48–5.59) 0.42*
Age in months (Median [IQR]) 20.7 (14.9–26.2) 21.4 (14.5–33.6)
Age category, N (%)
< 1 32 15,69% 2 18,2% 1
1–2 107 52,45% 5 45,5% 0.75 (0.14–4.06)
2-+ 65 31,86% 4 36,4% 0.98 (0.17–5.71) 0.84*
BCG Scar
Absent 31 15,20% 4 36,4% 1
Present 172 84,31% 7 63,6% 0.31 (0.09–1.16) 0.08
TB contact (documented or reported)
No 188 92,16% 10 90,9% 1
Yes 16 7,84% 1 9,1% 1.17 (0.14–9.82) 0.61
Number of consultations in previous year
Median (IQR)
< 10 179 87,75% 6 54,5% 1
10 - + 25 12,25% 5 45,5% 5.97 (1.64–21.69) 0.01
Symptoms at enrollment
Cough2 weeks
no 167 81,86% 5 45,5% 1
Yes 37 18,14% 6 54,5% 5.41 (1.52–19.24) 0.01
Fever2 weeks
no 197 96,57% 7 63,6% 1
yes 7 3,43% 4 36,4% 16.08 (3.48–74.27) < 0.001
Chronic or Acute Malnutrition malnutrition
no 21 10,29% 5 45,5% 1
yes 183 89,71% 6 54,5% 0.14 (0.04–0.51) < 0.001
Wheeze
no 201 98,53% 10 90,9% 1
yes 3 1,47% 1 9,1% 6.7 (0.62–72.00) 0.07
Adenopathy
no 202 99,02% 10 90,9% 1
yes 2 0,98% 1 9,1% 10 (0.81–125.30) 0.03
Number of positive criteria
One 164 80,39% 5 45,5% 1
More than one 40 19,61% 6 54,5% 4.92 (1.39–17.37) 0.006
Hospitalized during TB presumption
no 193 94,61% 8 72,7% 1
yes 11 5,39% 3 27,3% 6.58 (1.48–29.23) 0.004
Physical Exam
Abnormal lung exam
no 200 98,04% 8 72,7% 1
yes 4 1,96% 3 27,3% 18.7 (3.26–107.65) < 0.001
Fever
no 201 99,50% 9 90,0% 1
(Continued )
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likely to be classified as probable or possible TB, more likely to initiate isoniazid preventive
therapy (IPT), and time to treatment initiation was shorter.
Most patients (88.4%), regardless of the initial culture result (204 NTM, 11 MTB, 567 nega-
tive), had at least one follow-up visit. Among them, 14.8% had follow-up samples collected
with an overall prevalence of NTM of 21.6%. This number was the same for those children
with an NTM compared to a negative sample at admission (22.2 vs. 21.6 respectively).
Table 3. (Continued)
NTM (N, %) MTB (N, %) Univariate
204 11 OR (95% CI) p
yes 1 0,50% 1 10,0% 22.33 (1.20–414.94) 0.002
Lymphadenoapthy
no 202 99,02% 10 90,9% 1
yes 2 0,98% 1 9,1% 10.1 (0.81–125.30) 0.03
Tuberculin skin test
Negative 173 85,22% 10 90,9% 1
Positive 30 14,78% 1 9,1% 0.58 (0.07–4.70) 0.6
HIV Reported
Not positive 180 88,24% 9 81,8% 1
Positive 24 11,76% 2 18,2% 1.66 (0.34–8.21) 0.53
Radiological changes suggestive of TB
No 164 82,41% 2 22,22% 1
Yes 35 17,59% 7 77,78% 16.4 (3.00–89.60) < 0.001
Abbreviations: NTM: Nontuberculous mycobacteria; MTB: M. tuberculosis; OR: odds ratio; IQR: Interquartile range; TB: Tuberculosis.
* = p values calculated using the Fisher’s exact test.
doi:10.1371/journal.pone.0169757.t003
Table 4. Outcomes and follow-up information according to culture result at admission.
Outcomes NTM (N, %) MTB (N, %) Negative (N, %)
204 11 567
TB case type*
Confirmed 0 11 0
Probable 7 3,43% 0 25 4,41%
Possible 48 23,53% 0 48 8,47%
MTB infection 24 11,76% 0 21 3,70%
Unlikely TB 125 61,27% 0 473 83,42%
Isoniazide preventive treatment
No 181 88,73% 11 100% 527 92,95%
Yes 23 11,27% 0 0% 40 7,05%
TB treatment
No 194 95,10% 4 36,4% 534 94,18%
Yes 10 4,90% 7 63,6% 33 5,82%
Median time to treatment initiation (days), N (IQR) 51 (41–100) 35 (33–63) 140 (48–233)
Mortality at 24 months
No 190 93,14% 8 72,7% 529 93,30%
Yes 14 6,86% 3 27,3% 38 6,70%
Abbreviations: NTM: Nontuberculous mycobacteria; MTB: M. tuberculosis; TB: Tuberculosis; IQR: Interquartile range.
* NIH TB case definition
doi:10.1371/journal.pone.0169757.t004
High Rates of Pediatric NTM Isolation
PLOS ONE | DOI:10.1371/journal.pone.0169757 January 17, 2017 7 / 12
Discussion
To our knowledge, this is the first study reporting the rate of NTM isolation in children in
Mozambique and one of the few in Sub-Saharan Africa. Our findings suggest that NTM isola-
tion in GA and IS samples of presumptive childhood TB cases is very frequent but may not be
clinically significant in this patient cohort. Thus, in high TB endemic countries, NTM isolation
complicates patient management as the underlying diagnosis is most often assumed to be TB.
Recent studies in TB endemic countries have reported high rates of NTM isolation in pre-
sumptive TB cases[10,19–22]. Adult studies in Nigeria and Uganda have shown a significant
increase in NTM isolation rate from 1–4% in older studies using solid media to 15% in more
recent ones in which liquid media were used [23]. In our cohort the yield of NTM was signifi-
cantly higher in liquid than solid culture in agreement with the results of a meta-analysis show-
ing that liquid culture alone has a 66% sensitivity compared with 51% for solid media alone
[24]. The single published paper reporting NTM isolates in Mozambique detected NTM iso-
lates in the sputum of 3 out of 320 HIV infected adults [25]. In children tested for tuberculosis,
several reports have described frequent NTM isolates both in gastric aspirates and in sputum,
ranging from 4 to 10%[9,10,26,27]. Although some authors detected a higher yield of induced
sputum versus gastric lavage[10], in our study the rate was similar for both types of samples.
Once isolated in a respiratory sample, it is often difficult to distinguish whether the NTM
are causally related to the clinical disease, simply a reflection of recent environmental expo-
sure, or a contaminant in biological specimen related to the sampling technique or laboratory
equipment[28]. Environmental exposure to NTM has been hypothesized to increase as chil-
dren grow older [9,10]; differences in prevalence among children of different age were also
observed in the current study, but there was no clear increase with increasing age. In our
study, the rate of isolation and the distribution of species did not vary substantially throughout
the study period, which renders systematic NTM laboratory contamination unlikely. Although
sterile water was used for the sampling procedures, systematic decontamination of the oral
cavity was not performed and thus, we cannot rule out the possibility of contamination of the
mouth/gastrointestinal tract immediately prior to the sampling process.
A symptomatic child with a positive culture yielding NTM does not indicate pulmonary
disease per se [1] and does not necessarily require treatment [10]. In this cohort, we believe
that the isolated NTM were not clinically significant. Firstly, none of the children received
NTM specific treatment and all 3 symptomatic cases that fulfilled the microbiological and
radiological criteria for NTM lung disease were alive and well two years later. Secondly, we
observed that the proportion of children with an NTM isolate at a follow-up visit was the same
regardless of the initial culture result. Finally, and although we could not compare our results
to a control group, the 2 year all-cause mortality did not increase as compared to those chil-
dren with negative cultures. On the other hand, children with MTB isolates had a worse clini-
cal and radiological presentation and higher two year all-cause mortality than those with
NTM. These results are similar to those published by Hatherill et al, who reported that pre-
sumptive TB cases with NTM isolates were less likely to demonstrate radiological features
compared to MTB. However, they did see an association between NTM and older age, consti-
tutional symptoms and lower rates of positive TST[10].
We did observe that isolating an NTM decreased the odds of ruling out TB according to
NIH case definition as compared to children with negative culture at admission (Table 4).
Besides, children with NTM isolates were more likely to initiate IPT and although there were
no differences in the proportion of children initiating treatment, time to treatment initiation
was much shorter if a NTM was found on admission. Without molecular methods, often
unavailable in TB endemic countries, a positive sputum smear for NTM is likely to be
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misinterpreted as tuberculosis. In this study, almost half of the positive smears were due to
NTM. These findings highlight that NTM isolates can pose a clinically significant obstacle to
the accurate diagnosis of childhood tuberculosis, potentially overdiagnosing the TB cases. This
is particularly important when designing TB vaccine trials for two reasons: firstly, because
NTM exposure may affect the efficacy of BCG vaccination [8,29]; secondly, because the pres-
ence of NTM in respiratory samples can interfere with the NIH diagnosis of TB as shown in
this study.
The distribution of NTM species in this study is similar to what has been reported in South
Africa in a collaborative NTM-NET study[30], where M. intracellulare was the most frequent
isolate, followed by M. scrofulaceum and gordonae. Similar to the South African data in the
NTM NET study, M. malmoense, which historically was considered to be restricted to Scandi-
navia and north-western Europe, was identified in our cohort.
Several challenges are presented when a clinician is managing a suspected case of childhood
NTM pulmonary disease. Besides being clinically and radiologically indistinguishable from
TB, current guidelines do not provide specific advice for diagnosis of NTM in children. The
clinical significance is difficult to establish and often requires longer follow-up and obtainment
of several confirmatory samples. In our setting, even if NTM disease was accurately diagnosed
in children, treatment is challenging as the availability of rifampicin or ethambutol are limited
outside the National TB Program, which only manages tuberculosis cases. Moreover, child
friendly formulations are often unavailable and treatment is lengthy and with common side
effects[18].
This study had several limitations. Firstly, we do not have a control group to provide data
on NTM isolation rates in healthy children nor can we assess the impact of not decontaminat-
ing the oral cavity prior to the procedure. Culture negative presumptive TB cases can be a het-
erogeneous group which can potentially include unidentified culture negative TB. Secondly,
only pulmonary samples were obtained and thus, there is no information regarding possible
NTM lymphadenitis. Thirdly, as stated before, laboratory contamination, although unlikely,
cannot be ruled out completely.
In summary, NTM isolation is frequent in children evaluated for presumed TB in Mozam-
bique and can contribute to overdiagnosing TB. Further studies are needed to understand the
epidemiology of NTM in children, including the environmental exposure in other rural Sub-
Saharan African settings and the relationship between NTM isolation and BCG efficacy. There
is a need for pediatric TB guidelines to discuss the role of NTM isolates and better orient the
clinician attending presumptive TB children from high burden TB and low resource countries.
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